ARCHIVES

Agency Expands Gleevec Label To Include Rare GIST Subset

This article is from The Cancer Letter archive.

Vol. 35 No. 2 | February 24, 2012

Download PDF Visit The Full Archive

Related Articles

ACS Defends Dialogue, Calls Story “Misleading”.

October 20, 2000

ASCO Publishes Two Clinical Guidelines For Treating HER2-Positive Breast Cancer

May 30, 2014

NCI Study Says 2 Million US Women Could Benefit from Tamoxifen

April 11, 2003

Obituaries: Keith Amos, Trudy Small, and Kie Kian Ang

June 21, 2013

NCI Advisory Group Meetings for July

June 27, 1975

Cancer Meetings Listed

April 18, 1997